Cost-Effectiveness Evaluation, including cognitives outcomes, of Vortioxetine in Patients With Major Depressive Disorder Switching From First Antidepressant Therapy in the United States
HomePublicationsCost-Effectiveness Evaluation, including cognitives outcomes, of Vortioxetine in Patients With Major Depressive Disorder Switching From First Antidepressant Therapy in the United States
Cost-Effectiveness Evaluation, including cognitives outcomes, of Vortioxetine in Patients With Major Depressive Disorder Switching From First Antidepressant Therapy in the United States
2017 ISPOR
Kokuvi, A. | Ereshefsky, L. | Francois, C. | Diamand, F. | Brignone, M. | Briquet, B. | Muchal, L. | Danchenko, N. |
Volume: ,
Issue: ,
Pages: ,
